Smoore International Ranked 211 on Hurun China 500 Most Valuable Private Companies 2024

Feb.27
Smoore International Ranked 211 on Hurun China 500 Most Valuable Private Companies 2024
On February 25, Hurun Research Institute released the "2024 Hurun China 500 Most Valuable Private Companies", ranking non-state-owned enterprises.

On February 25, the Hurun Research Institute released the "2024 Hurun China 500 Most Valuable Private Companies", which lists the top 500 private companies in China based on their enterprise value. The market value of listed companies is calculated based on the closing price on November 15, 2024, while the valuation of non-listed companies is estimated based on comparable listed companies in the same industry or the latest round of financing. This is the sixth consecutive year that the Hurun Research Institute has released the "Hurun China 500 Most Valuable Private Companies".

Smoore International Ranked 211 on Hurun China 500 Most Valuable Private Companies 2024
Smoore International ranks 211th in the "2024 Hurun China Top 500" | Image source: Hurun


Among them, Smoore International ranked 211th on the list with an enterprise value of 55.5 billion yuan, rising 102 places from the previous year, and is the only e-cigarette company on the list.


According to reports, Rupert Hoogewerf, a British national, founded the Hurun Report in 1999, creating China's first wealth ranking list, the "Hurun Rich List." The Hurun Report is renowned for its series of rich lists, focusing on studying the achievements of Chinese businesses and successful entrepreneurs globally.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.